Should you buy Arena (Arna) stock?

Investors need to pay close attention to Arena (ARNA) stock based on the movements in the options market lately. While the sector is under pressure, these biotech stocks have key catalysts in March Pre-Market Brief: Stocks Give Up Overnight Gains as the U.S. Will Ban Russian Energy Exports Barchart - Tue Mar 8, 2022

Why did Arena & Pfizer share prices rise?

Image Source: Zacks Investment Research This rise is primarily attributable to a definitive agreement entered by Arena last month with Pfizer PFE, wherein the latter will acquire the former in an all-cash transaction for $100 per share or a total equity value of approximately $6.7 billion.

Is Arena a marketable product?

Currently, Arena has no marketable products in its portfolio. The company’s late-stage candidate, etrasimod, is being evaluated in two pivotal phase III studies evaluating etrasimod for treating ulcerative colitis (“UC”). Top-line data from both the studies are expected in first-quarter 2022.